Holen Sie sich die Stockscreener-App
0.0066
0.00%
0.00
Schlusskurs vom Vortag:
$0.0066
Offen:
$0.0067
24-Stunden-Volumen:
1.07M
Relative Volume:
26.11
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
$-82.19M
KGV:
-0.00213
EPS:
-3.0969
Netto-Cashflow:
$-8.35M
1W Leistung:
+0.00%
1M Leistung:
+37.50%
6M Leistung:
-98.75%
1J Leistung:
-99.22%
1-Tages-Spanne:
$0.0057
$0.0069
1-Wochen-Bereich:
$0.0057
$0.0069
52-Wochen-Spanne:
$0.0045
$0.0069
Ocean Biomedical Inc Stock (OCEA) Company Profile
Firmenname
Ocean Biomedical Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie OCEA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OCEA
Ocean Biomedical Inc
|
0.0066 | 0 | 0 | -82.19M | -8.35M | -3.0969 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.85 | 103.64B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
600.00 | 63.59B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.99 | 60.38B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
791.59 | 46.96B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
345.17 | 36.81B | 4.56B | -176.77M | 225.30M | -1.7177 |
Ocean Biomedical Inc Aktie (OCEA) Neueste Nachrichten
What consensus target says about Ocean Biomedical Inc. (8AW0) stock2025 Trading Volume Trends & Real-Time Market Trend Scan - newser.com
Why global investors buy Ocean Biomedical Inc. (8AW0) stockQuarterly Trade Review & Real-Time Volume Surge Alerts - newser.com
Will Ocean Biomedical Inc. (8AW0) stock hit Wall Street targetsMarket Growth Report & Free Long-Term Investment Growth Plans - newser.com
How Ocean Biomedical Inc. (8AW0) stock performs in volatility spikesTrade Entry Report & Risk Adjusted Swing Trade Ideas - newser.com
Ocean Biomedical Inc 8AW0 Stock Analysis and ForecastDay Trading Setups & Invest Smarter With Data-Driven Models - earlytimes.in
What drives Ocean Biomedical Inc 8AW0 stock priceEarnings Miss Alerts & Rapid Portfolio Strategies - earlytimes.in
Biotech Stocks Are Tumbling — But The Top 5 Are Standouts - Investor's Business Daily
Ocean Biomedical stock plunges to 52-week low of $0.28 - MSN
North American Morning Briefing : Stock Futures Flat; U.S.-China Relations in Focus -2- - MarketScreener
SPACs, Executives Beat Investor’s Shell Company Accusations (1) - Bloomberg Law News
Biotech Sector Stocks Witnessing Increased Search Activity - AInvest
Orchestra BioMed stock rating downgraded to Neutral from Buy by BTIG - Investing.com
Ocean Biomedical Delays 10-Q Filing - MSN
Delisting of Securities from The Nasdaq Stock Market - The Manila Times
Ocean Biomedical Faces Imminent Nasdaq Delisting - TipRanks
Orchestra BioMed director Hochman buys $55,000 in OBIO stock - Investing.com
Orchestra BioMed announces public offering of common stock - Investing.com
Ocean Biomedical to be delisted from Nasdaq following appeal denial By Investing.com - Investing.com South Africa
Ocean Biomedical to be delisted from Nasdaq following appeal denial - Investing.com
Ocean Biomedical licenses with Elkurt terminated following breach notice By Investing.com - Investing.com India
Ocean Biomedical Faces License Termination by Elkurt - TipRanks
Ocean Biomedical licenses with Elkurt terminated following breach notice - Investing.com
Biotech Stocks Surge in Interest: iBio, Fractyl Health, Hepion Pharmaceuticals, and Ocean Biomedical See Significant Search Activity - AInvest
Ocean Biomedical faces license terminations over breaches - Investing.com
Ocean Biomedical faces license terminations over breaches By Investing.com - Investing.com Nigeria
Ocean Biomedical Faces License Termination Notice - TipRanks
SEC filing of the week: Ocean Biomedical posts $8.42M loss in Q1 - Providence Business News
Sidoti Events, LLC's Virtual June Small-Cap Conference - The Globe and Mail
Wellgistics Health Strengthens Executive Team and Board with Strategic Appointments to Accelerate Scale and Drive Shareholder Value - Voice of Alexandria
Finanzdaten der Ocean Biomedical Inc-Aktie (OCEA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.47%
0.48%
Kapitalisierung:
|
Volumen (24h):